This is also in line with a recent study investigating CSF and serum levels of 36 cytokines and chemokines in MS patients, revealing a significant correlation of CSF and serum levels in only three cases (namely, CCL23, also known as MIP-3; CCL27 and IL-6) (64). This evidence concerns the gene CCL23 and myeloid sarcoma.